Todd Kole Appointed to Almac's Clinical Technologies Executive Team

By Almac Group, PRNE
Thursday, May 5, 2011

CRAIGAVON, Northern Ireland, May 6, 2011 - Almac's Clinical Technologies business unit announced today that Todd
has joined the Company as Vice President of Clinical Project Services
(CPS) and a member of the Executive Leadership Team. As Vice President of
CPS, Todd will report directly to the President of Almac Clinical
Technologies and will oversee clinical project management and drug supply
services globally.

Mr. Kole has extensive experience in the biopharmaceuticals industry,
with specialized expertise in clinical technologies and clinical supplies
management. He has served in a variety of capacities involving the provision
of Interactive Voice and Web Response Systems (IVR/IWR) technologies,
clinical and technology personnel management, as well as global project and
client account management.

Mr. Kole joins Almac after spending 12 years at Clinphone and Perceptive
Informatics. At Clinphone, Mr. Kole served as Director of US Operations
before being promoted to Vice President of Global Client Services. In
operations roles at Clinphone he was responsible for approximately 175 staff,
ensuring operational accountability in managing the quality and timeliness of
IVRS design, build, delivery and support. As VP of Client Services at
Clinphone, he held global oversight responsibilities for the Project
Management and Client Account Management divisions. During his tenure as Vice
President of IVR Operations at Perceptive Informatics, Mr. Kole held P&L
responsibilities and was a member of the Perceptive Executive Management
Team. In that role, he was integral in working with clients and operations
personnel during the acquisition of Clinphone by Perceptive Informatics.

Jim Murphy, President of Almac's Clinical Technologies business unit
comments on Mr. Kole's appointment: "We are very pleased that Todd Kole has
joined Almac. He brings a tremendous amount of industry experience to our
firm that will help Almac maintain high levels of operational excellence as
we continue to grow. Further, given the depth of his drug supply expertise,
Todd will be instrumental to the continuing advancement of Almac's market
leading total drug supply chain management service. We welcome Todd to Almac
and know he will have a profound impact on the development of the team and
our client relationships."

About Almac Group

The Almac Group provides a broad range of services from R&D, biomarker
discovery and development, API manufacture, formulation development, clinical
trial supply and IXRS(R) technology (IVRS/IWRS), to commercial-scale
manufacture. Almac provides services to more than 600 companies, including
all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 3,000 individuals and is headquartered in
Craigavon, Northern Ireland. US operations are based in Pennsylvania, North
and California. Almac has now moved into its new North American
Headquarters located in Souderton PA.

Almac's Clinical Technologies business unit specializes in interactive
technology and service solutions to increase the quality and efficiency of
clinical trials. Our solutions include Interactive Voice and Web Response
Systems (IXRS(R)) for patient randomization and drug assignment, patient and
clinical supplies management, electronic-patient-reported-outcomes data
collection, and Web drug reconciliation. Almac's technologies have been
deployed in over 1600 clinical trials, incorporating over 1.5 million
patients in over 80 countries, and more than 60 languages.

For more information about the Almac Group, please visit or e-mail

    Kristi Bronico
    T: (1) 215-660-8500


will not be displayed